Actinogen Medical's market value is the price at which a share of Actinogen Medical trades on a public exchange. It measures the collective expectations of Actinogen Medical Limited investors about its performance. Actinogen Medical is trading at 0.04 as of the 26th of December 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.04. With this module, you can estimate the performance of a buy and hold strategy of Actinogen Medical Limited and determine expected loss or profit from investing in Actinogen Medical over a given investment horizon. Check out Actinogen Medical Correlation, Actinogen Medical Volatility and Actinogen Medical Alpha and Beta module to complement your research on Actinogen Medical.
Please note, there is a significant difference between Actinogen Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Actinogen Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Actinogen Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Actinogen Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Actinogen Medical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Actinogen Medical.
0.00
11/26/2025
No Change 0.00
0.0
In 31 days
12/26/2025
0.00
If you would invest 0.00 in Actinogen Medical on November 26, 2025 and sell it all today you would earn a total of 0.00 from holding Actinogen Medical Limited or generate 0.0% return on investment in Actinogen Medical over 30 days. Actinogen Medical is related to or competes with Vicapsys Life, Zivo Bioscience, Biostem Technologies, Relief Therapeutics, and Helix BioPharma. Actinogen Medical Limited, a biotechnology company, develops therapies for cognitive impairment associated with chronic ... More
Actinogen Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Actinogen Medical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Actinogen Medical Limited upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Actinogen Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Actinogen Medical's standard deviation. In reality, there are many statistical measures that can use Actinogen Medical historical prices to predict the future Actinogen Medical's volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Actinogen Medical. Your research has to be compared to or analyzed against Actinogen Medical's peers to derive any actionable benefits. When done correctly, Actinogen Medical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Actinogen Medical.
Actinogen Medical Backtested Returns
Actinogen Medical appears to be out of control, given 3 months investment horizon. Actinogen Medical secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. By analyzing Actinogen Medical's technical indicators, you can evaluate if the expected return of 0.94% is justified by implied risk. Please makes use of Actinogen Medical's Standard Deviation of 7.5, mean deviation of 1.85, and Risk Adjusted Performance of 0.097 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Actinogen Medical holds a performance score of 9. The firm shows a Beta (market volatility) of 0.13, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Actinogen Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Actinogen Medical is expected to be smaller as well. Please check Actinogen Medical's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to make a quick decision on whether Actinogen Medical's price patterns will revert.
Auto-correlation
1.00
Perfect predictability
Actinogen Medical Limited has perfect predictability. Overlapping area represents the amount of predictability between Actinogen Medical time series from 26th of November 2025 to 11th of December 2025 and 11th of December 2025 to 26th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Actinogen Medical price movement. The serial correlation of 1.0 indicates that 100.0% of current Actinogen Medical price fluctuation can be explain by its past prices.
Correlation Coefficient
1.0
Spearman Rank Test
1.0
Residual Average
0.0
Price Variance
0.0
Actinogen Medical lagged returns against current returns
Autocorrelation, which is Actinogen Medical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Actinogen Medical's pink sheet expected returns. We can calculate the autocorrelation of Actinogen Medical returns to help us make a trade decision. For example, suppose you find that Actinogen Medical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Actinogen Medical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Actinogen Medical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Actinogen Medical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Actinogen Medical pink sheet over time.
Current vs Lagged Prices
Timeline
Actinogen Medical Lagged Returns
When evaluating Actinogen Medical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Actinogen Medical pink sheet have on its future price. Actinogen Medical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Actinogen Medical autocorrelation shows the relationship between Actinogen Medical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Actinogen Medical Limited.
Other Information on Investing in Actinogen Pink Sheet
Actinogen Medical financial ratios help investors to determine whether Actinogen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Actinogen with respect to the benefits of owning Actinogen Medical security.